Fusing innovation and biotech for a more progressive tomorrow

Helping transform patient care, for patients to live better and healthier lives.


Our advanced imaging solutions are aimed to accelerate the progress of physicians all over the world, ending the need for repeat, painful biopsies and giving patients greater comfort and clarity through their individual cancer journeys. Join us as we reimagine a new vision and approach towards immuno oncology patient care paths. Explore more about who we are, how we innovate for tomorrow and why partnering with us will help to challenge, create and transform patient care.

Our Technology

CD8 ImmunoPET imaging technology

CD8 ImmunoPET imaging technology

Our technology uses ‘minibody’ antibodies to scan patients head-to-toe, delivering an in-depth visual profile of immunity status, before, during and after treatment.

Discover CD8 ImmunoPET
Target RPT platform

Target RPT platform

Using our minibody and cys-diabodies platform technologies we are generating best in class RPT solutions, to kill tumor cells with targeted radiation.

Discover RPT

Tomorrow’s cancer patient care paths begin here…

PET Imaging

Indication
Preclinical
IND
Phase 1
Phase 2
Phase 3
PET imaging of CD8 Cells in Oncology (89Zr-Df-Crefmirlimab)
 
 
 
 
 
PET imaging CD8 T-cells in Inclusion Body Myositis (89Zr-Df-Crefmirlimab)
 
 
 
 
 
PET Imaging CD8 T-cells trafficking in Oncology and Autoimmune diseases (89Zr-Df-IAB41M2C)
 
 
 
 
 

Optical Imaging

Indication
Preclinical
IND
Phase 1
Phase 2
Phase 3
PSMA optical imaging: Prostate Cancer (IR800-IAB2MA)
 
 
 
 
 
PSMA optical imaging: Renal Cancer (IR800-IAB2MA)
 
 
 
 
 

Radio Pharmaceutical Therapy (RPT)

Indication
Preclinical
IND
Phase 1
Phase 2
Phase 3
Prostate Cancer - PSMA (177Lu-DOTA-IAB2MA)
 
 
 
 
 
Solid tumors (undisclosed targets)
 
 
 
 
 

Discover our pipeline of next generation biotech innovations.

scan

Meet the team striving to create, challenge and transform the future of immuno oncology patient care paths.

At ImaginAb, everything we do is underpinned by medical expertise and scientific innovation. And our people are paramount to that.

Meet the team

Join us to reimagine the future of immuno oncology.